Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism

NCT00004763 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Hyperandrogenism

Interventions

DRUG: leuprolide
DRUG: Ethinyl estradiol/norethindrone

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]